Ejder P, Jespersen H, Hernberg M, Ny L, et al. Grand SLAM study protocol: a prospective randomised multicentre study of shortened versus standard duration adjuvant immune checkpoint inhibition for stage IIB-C, III and IV cutaneous melanoma. BMC Cancer 2026 Mar 27. doi: 10.1186/s12885-026-15924.
PMID: 41896823